Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  PDL BioPharma, Inc.    PDLI

PDL BIOPHARMA, INC.

(PDLI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

PDL BIOPHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
09/10/2020 | 04:04pm EDT

Item 7.01 Regulation FD Disclosure.

On September 10, 2020, PDL BioPharma, Inc. posted to its website presentation materials that it will use during its webcast providing a business update on LENSAR, Inc. A copy of this presentation is attached hereto as Exhibit 99.1.

Limitation of Incorporation by Reference

In accordance with General Instruction B.2. of Form 8-K, this information, including the Exhibit, is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information that is required to be disclosed solely by Regulation FD.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
                          Exhibit No.          Description
                               99.1           Presentation



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses


share with twitter share with LinkedIn share with facebook
All news about PDL BIOPHARMA, INC.
10/07PDL BIOPHARMA, INC. : Completion of Acquisition or Disposition of Assets, Financ..
AQ
10/05PDL BIOPHARMA : Completes Spin-Off of LENSAR
AQ
10/02PDL BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
10/02PDL BIOPHARMA, INC. : Spin off
FA
09/10PDL BIOPHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
09/10PDL BIOPHARMA : Completes Divestiture of the Noden Pharmaceutical Business to St..
AQ
09/10PDL BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/09PDL BIOPHARMA, INC. : Completion of Acquisition or Disposition of Assets, Financ..
AQ
09/01PDL BIOPHARMA : Announces Sale of Kybella Zalviso and Coflex Royalties to SWK Ho..
AQ
09/01PDL BIOPHARMA, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal..
AQ
More news